Who qualifies for testosterone replacement therapy (TRT)?
Candidates typically present with documented low testosterone on the standardized biomarker panel plus correlating symptoms — fatigue, low libido, poor recovery, mood, body-composition change. Candidacy is provider-reviewed and weighs cardiovascular history, hematocrit, fertility goals, and current medications. The assessment surfaces non-candidates before initiation.
Full answer
Candidacy for TRT is not a single number. The clinical read combines three layers: (1) biomarkers — total and free testosterone, SHBG, estradiol, LH, FSH read against optimization ranges, with hematocrit, lipids, and metabolic markers as safety context; (2) symptoms — persistent fatigue, low libido, erectile changes, poor recovery, mood drift, sleep disruption, body-composition change; and (3) history — cardiovascular events, sleep apnea, prostate history, fertility goals, current medications (especially opioids, glucocorticoids), and lifestyle vectors (sleep, training, alcohol). Men who want to preserve fertility may be routed to enclomiphene rather than exogenous testosterone. Men with uncontrolled erythrocytosis, active prostate cancer, or specific cardiovascular contraindications are typically not candidates until those are addressed. The optimization assessment is designed to surface non-candidates before initiation, not after.
Educational. Not a substitute for individualized provider review.
- Testosterone optimization pathway — Primary source · oMeds
- Reviewed by Dr. Laura Purdy, MD, MBA · Clinical Director, oMeds · Last reviewed 2026-05-29

